Skip to main content
Log in

Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes

  • Original Paper
  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Background

Variables associated with treatment satisfaction (TS) can be broadly categorized as precursors, ongoing treatment issues, and treatment outcomes. This study continues the validation process for the Insulin Treatment Satisfaction Questionnaire (ITSQ) while examining relationships between TS and these broader influences.

Methods

Data (N = 299) were collected in a RCT comparing safety and efficacy of inhaled vs. injectable insulin. Validation examined item and factor characteristics, reliability and validity. Regression analyses examined relationships between overall and domain specific TS and the broader influences.

Results

Patients with less previous or current treatment burden had greater TS (p < 0.001). Gender, injection fear, functioning, age, compliance and glycemic control were differentially related to TS at the beginning and end of study. Baseline satisfaction was predictive of future TS (p < 0.001). When all significant factors were examined together, lower burden with the current treatment and higher satisfaction with previous treatment continued to be key (p < 0.001) while other factors were no longer significant. Validation findings confirmed the ITSQ was psychometrically sound.

Conclusion

Over the course of treatment, some factors are associated with TS at treatment start while others are key drivers at treatment end. This suggests that TS is not a static concept.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

D-FISQ:

Diabetes fear of self-injection questionnaire

DS:

Insulin delivery device satisfaction subscale

GC:

Glycemic control subscale

HC:

Hypoglycemic control subscale

HRQoL:

Health-related quality of life

IR:

Inconvenience of regimen subscale

ITSQ:

Insulin treatment satisfaction questionnaire

LF:

Lifestyle flexibility subscale

NPH:

Basal insulin

PRO:

Patient-reported outcome

SAP:

Statistical analysis plan

TS:

Treatment satisfaction

References

  1. Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329, 977–986.

    Article  Google Scholar 

  2. UK Prospective Diabetes Study (UKPDS) Group (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet, 352, 837–853.

    Google Scholar 

  3. Weaver, M., Patrick, D. L., Markson, L. E., Martin, D., Frederic, I., & Berger, M. (1997). Issues in the measurement of satisfaction with treatment. American Journal of Managed Care, 3, 579–594.

    PubMed  CAS  Google Scholar 

  4. Cappelleri, J. C., Gerber, R. A., Kourides, I. A., & Gelfand, R. A. (2000). Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes. Diabetes Care, 23, 1799–1803.

    Article  PubMed  CAS  Google Scholar 

  5. Redekop, W. K., Koopmanschap, M. A., Stolk, R. P., Rutten, G. E. H. M., Wolffenbuttel, B. H. R., & Niessen, L. W. (2002). Health-related quality of life and treatment satisfaction in Dutch patients with Type 2 diabetes. Diabetes Care, 25, 458–463.

    Article  PubMed  Google Scholar 

  6. Taylor, M. D., Frier, B. M., Gold, A. E., & Beary, I. J. (2003). Psychosocial factors and diabetes-related outcomes following diagnosis of type 1 diabetes in adults: the Edinburgh prospective diabetes study. Diabetes Medicine, 20, 135–146.

    Article  CAS  Google Scholar 

  7. Ahlgren, S. S., Shultz, J. A., Massey, L. K., Hicks, B. C., & Wysham, C. (2004) Development of a preliminary diabetes dietary satisfaction and outcomes measure for patients with type 2 diabetes. Quality of Life Research, 13, 819–832.

    Article  PubMed  CAS  Google Scholar 

  8. Anderson, R. T., Skovlund, S. E., Marrero, D., Levine, D. W., Meadows, K., Brod, M., & Balkrishnan, R. (2004). Development and validation of the insulin treatment satisfaction questionnaire. Clinical Therapeutics, 26, 565–578.

    Article  PubMed  Google Scholar 

  9. Royle, P., Waugh, N., McAuley, L., McIntyre, L., & Thomas, S. (2003). Inhaled insulin in diabetes mellitus. The Cochrane Database of Systematic Reviews. Issue 4. Art. No.: CD003890.pub.2.

  10. Atkinson, M. J., Kumar, R., Cappelleri, J. C., & Hass, S. L. (2005). Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM Version ll) among outpatient pharmacy consumers. Value in Health, 8(1), 9–24.

    Article  Google Scholar 

  11. Dunbar-Jacob, J., & Mortimer-Stephens, M. K. (2001). Treatment adherence in chronic disease. Journal of Clinical Epidemiology, 54 (Suppl 1), S57–S60 (Review).

    Google Scholar 

  12. Robiner, W. N. (2005). Enhancing adherence in clinical research. Contemporary Clinical Trials, 26(1), 59–77 (Review).

    Google Scholar 

  13. Piette, J. D., Wagner, T. H., & Potter, M. B., et al. (2004). Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Medical Care, 42(2), 102–109.

    Article  PubMed  Google Scholar 

  14. Haynes, R. B., McKibbon, K. A., & Kanani, R. (1996). Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet, 348(9024), 383–386.

    Article  PubMed  CAS  Google Scholar 

  15. Leo, R. J., Jassal, K., & Badhai, Y. D. (2005). Nonadherence with psychopharmacologic treatment among psychiatric patients. Primary Psychiatry, 12(6), 33–39.

    Google Scholar 

  16. Gerber, R. A, Cappelleri, J. C, Kourides, I. A., & Gelfand, R. A. (2001). Treatment satisfaction with inhaled insulin in patients with type 1 diabetes. Diabetes Care, 24, 1556–1559.

    Article  PubMed  CAS  Google Scholar 

  17. Hollander, P. A., Blonde, L., Rowe, R., Mehta, A. E., Milburn, J. L., Hershon, K. S., Chiasson, J., & Levin, S. R. (2004). Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes. Diabetes Care, 27, 2356–2362.

    Article  PubMed  CAS  Google Scholar 

  18. Quattrin, T., Belanger, A., Bohannon, N. J. V., & Schwartz, S. L. (2004). Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes. Diabetes Care, 27, 2622–2627.

    Article  PubMed  CAS  Google Scholar 

  19. Rosenstock, J., Cappelleri, J. C., Bolinder, B., & Gerber, R. A. (2004). Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes. Diabetes Care, 27, 1318–1323.

    Article  PubMed  Google Scholar 

  20. Raskin, P., Bode, B. W., Marks, J. B., Hirsch, I. B., Weinstein, R. L., McGill J. B., Peterson, G. E., Mudaliar, S. R., & Reinhardt, R. R. (2003). Continuous subcutaneous insulin infusion and multiple daily injection therapy and equally effective in type 2 diabetes: A randomized, parallel-group, 24-week study. Diabetes Care, 26, 2598–2603.

    Article  PubMed  CAS  Google Scholar 

  21. Weintrob, N., Benzaquen, H., Galatzer, A., Shalitin, S., Lazar, L., Fayman, G., Lilos, P., Dickerman, Z., & Phillip, M. (2002). Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: A randomized open crossover trial. Pediatrics, 112, 559–564.

    Article  Google Scholar 

  22. Bott, U., Ebrahim, S., Hirchberger, S., & Skovlund, S. E. (2003). Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with type 1 diabetes. Diabetes Medicine, 20, 626–634.

    Article  CAS  Google Scholar 

  23. Renner, R., Pfutzner, A., Trautmann, M., Harzer, O., Sauter, K., & Landgraf, R. (1999). Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Diabetes Care, 22, 784–788.

    Article  PubMed  CAS  Google Scholar 

  24. DeVries J. H., Snoek, F. J., Kostense, P. J., Masurel, N., & Heine, R. J. (2002). A randomized trial of continuous subcutaneous insulin infrion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care, 25, 2074–2080.

    Article  PubMed  CAS  Google Scholar 

  25. Herman, W. H., Ilag, L. L., Johnson, S. L., Martin, C. L., Sinding, J., Al Harthi, A., Plunkett, C. D., LaPorte F. B., Burke, R., Brown, M. B., Halter, J. B., & Raskin, P. (2005). A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care, 28, 1568–1573.

    Article  PubMed  CAS  Google Scholar 

  26. Janssen, M. M. J., Snoek, F. J., Masurel, N., Hoogma, R. P. L. M., Deville, W. L., Popp-Snijders, C., & Heine, R. J. (2000). Optimized based-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients. Diabetes Care, 23, 629–633.

    Article  PubMed  CAS  Google Scholar 

  27. Bech, P., Moses, R., & Gomis, R. (2003). The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy naïve Type 2 diabetes: A placebo-controlled, multicenter study. Quality of Life Research, 12, 413–425.

    Article  PubMed  Google Scholar 

  28. Atkinson, M. J., Sinha, A., Hass, S. L., Colman, S. S., Kumar, R. N., Brod, M., & Rowland, C. (2004). Validation of a general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease. Health and Quality of Life Outcomes, 2, 12–25.

    Article  PubMed  Google Scholar 

  29. Moses, R., Clauson, P., Vesterager, A., Roberts, A., & Wollmer, P. (2006). Inhaled preprandial human insulin (AERx iDMS) versus subcutaneous insulin aspart in type 1 diabetes. Poster presentation IDF, Cape Town, South Africa.

  30. Snoek, F. J., Mollema, E. D., Heine, R. J., Bouter, L. M., & van der Ploeg, H. M. (1997). Development and validation of the diabetes fear of injecting and self-testing questionnaire (D-FISQ): First findings. Diabetes Medicine, 14, 871–876.

    Article  CAS  Google Scholar 

  31. Mollema, E., Snoek, F., Pouwer, F., Heine, R., & Van Der Ploeg, H. (2000). Diabetes fear of injecting and self-testing questionnaire. Diabetes Care, 23(6), 765–769.

    Google Scholar 

  32. Kramer, J. (2006). The diabetes medication compliance scale (DMCS), measure under development.

  33. Anderson, R., Skovlund, S. E., Marrero, D., & Schwartz, S. (2003). Self-reported non-adherence with insulin injection therapy in people with type 1 and 2 diabetes. Poster presentation IDF, Paris, France.

  34. Welch, G. W., Weinger, K., Anderson, B., & Polonsky, W. H. (2003). Responsiveness of the problem areas in diabetes (PAID) questionnaire. Diabetic Medicine, 20, 69–72.

    Article  PubMed  CAS  Google Scholar 

  35. Welch, G. W., Jacobson, A. M., & Polonsky, W. H. (1997). The problem areas in diabetes scale: An evaluation of its clinical utility. Diabetes Care, 20, 760–766.

    Article  PubMed  CAS  Google Scholar 

  36. Ware, J. Jr., Kosinski, M., & Keller, S. D. (1996). A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medicine Care, 34, 220–233.

    Article  Google Scholar 

  37. Turner-Bowker, D. M., Bartley, P. J., & Ware, J. E. Jr. (2002). SF-36® health survey & “SF” bibliography: Third edition (1988–2000). Lincoln, RI: QualityMetric Incorporated.

    Google Scholar 

  38. Ware, J. E., Kosinski, M., & Dewey, J. E. (2000). How to score version two of the SF-36 health survey. Lincoln, RI: QualityMetric, Incorporated.

    Google Scholar 

  39. Cronbach, L. F. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297–334.

    Article  Google Scholar 

  40. Scientific Advisory Committee of the Medical Outcomes Trust (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research, 11, 193–205.

    Article  Google Scholar 

  41. Brod, M., Skovlund, S. E., & Wittrup-Jensen, K. (2006). Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Quality of Life Research, 15, 481–491.

    Article  PubMed  Google Scholar 

  42. Brod, M., Mendelson, G., & Roberts, B. (1998). Patient’s experience of Parkinson’s disease. Journal of Gerontology, 53B(4), 213–222.

    Google Scholar 

Download references

Acknowledgment

This project and manuscript was supported by a grant from Novo Nordisk, Denmark.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Meryl Brod.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brod, M., Christensen, T. & Bushnell, D. Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes. Qual Life Res 16, 1053–1063 (2007). https://doi.org/10.1007/s11136-007-9209-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-007-9209-1

Keywords

Navigation